glutathione parkinson treatment S-transferase: A keystone in Parkinson's disease pathogenesis and therapy The glutathione system in Parkinson's

(2024) designed biomimetic nanoparticlesTGN-decorated, erythrocyte membrane-coated PLGA nanocarriers (TRNNs)which significantly improved BBB penetration and naringenin brain accumulation

Ingles-Prieto A, et al

Recent studies have demonstrated that CoQ10 participates in several aspects of cell signaling and affects the expression of genes involved in metabolism, cell signaling and transport [21,22]

In this pathology astrocytes undergo mild reactive changes and often develop astro-tauopathy (see below)

[DOI] [PubMed] [Google Scholar] 82.Kang H.J., Baik H.W., Kim S.J., Lee S.G., Ahn H.Y., Park J.S., Park S.J., Jang E.J., Park S.W., Choi J.Y., et al